Analyst Reco. Keurig Dr Pepper Inc.

Equities

KDP

US49271V1008

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
32.34 ^USD	+1.83%		+4.73%	-2.94%

01:47pm	Earnings Flash (KDP) KEURIG DR PEPPER Reports Q1 Revenue $3.47B, vs. Street Est of $3.41B	MT
01:46pm	Earnings Flash (KDP) KEURIG DR PEPPER Posts Q1 EPS $0.38, vs. Street Est of $0.35	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Deutsche Bank Adjusts Keurig Dr Pepper Price Target to $34 From $33, Maintains Hold Rating	Apr. 15	MT
Consumer Edge Adjusts Keurig Dr Pepper's Price Target to $41 From $40	Apr. 15	MT
Barclays Adjusts Price Target on Keurig Dr Pepper to $36 From $32, Maintains Overweight Rating	Apr. 12	MT
Jefferies Cuts Keurig Dr Pepper's Price Target to $35 From $37, Keeps Buy Rating	Mar. 27	MT
Barclays Cuts Price Target on Keurig Dr Pepper to $32 From $34, Keeps Overweight Rating	Mar. 12	MT
ANALYST RECOMMENDATIONS : Block, Estee Lauder, Dell, Netflix, Nvidia...	Mar. 01
Morgan Stanley Cuts Price Target on Keurig Dr Pepper to $34 From $37, Keeps Equalweight Rating	Feb. 26	MT
Wedbush Lowers Keurig Dr Pepper's PT to $35 From $37 After Mixed Q4 2023 Results, Maintains Outperform Rating	Feb. 26	MT
Barclays Cuts Price Target on Keurig Dr Pepper to $34 From $37, Maintains Overweight Rating	Feb. 23	MT
Deutsche Bank Trims Keurig Dr Pepper Price Target to $33 From $34, Maintains Hold Rating	Feb. 23	MT
RBC Trims Price Target on Keurig Dr Pepper to $41 From $42, Keeps Outperform Rating	Feb. 23	MT
UBS Cuts Price Target on Keurig Dr Pepper to $36 From $38, Maintains Buy Rating	Feb. 20	MT
UBS Adjusts Keurig Dr Pepper Price Target to $38 From $37, Maintains Buy Rating	Jan. 16	MT
Morgan Stanley Downgrades Keurig Dr Pepper to Equalweight From Overweight, Price Target is $37	Jan. 03	MT
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	Jan. 03
Big tech saves the day	Nov. 13
ANALYST RECOMMENDATIONS : Airbnb, Apple, Best Buy, Diageo, Tesla...	Nov. 13
Barclays Raises Price Target on Keurig Dr Pepper to $36 From $34, Maintains Overweight Rating	23-10-30	MT
UBS Cuts Keurig Dr Pepper Price Target to $37 From $39, Maintains Buy Rating	23-10-27	MT
Morgan Stanley Cuts Price Target on Keurig Dr Pepper to $37 From $39, Maintains Overweight Rating	23-10-27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Keurig Dr Pepper Inc.

Equities

KDP

US49271V1008

Analyst Reco.

Filters